Wednesday, September 12, 2018

Epic Sciences Gets $52M More

San Diego-based Epic Sciences, which is developing technology around personalization of cancer treatment and management, has raised $52M more in a Series E funding, the company's lead investor said this morning. According to Blue Ox Healthcare Partners, it led the $52M investment, which are being used to accelerate Epic's clinical studies for oncolo

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.